Aerosol generation during percutaneous tracheostomy insertion

Aravind V Ramesh,Ivan Collin,Florence KA Gregson,Jules Brown
DOI: https://doi.org/10.1177/1751143720977278
2020-12-06
Journal of the Intensive Care Society
Abstract:The severe acute respiratory syndrome corona virus-2 (SARS-CoV-2) pandemic has resulted in significant changes to the use of personal protective equipment (PPE) in healthcare institutions worldwide. It is thought transmission is primarily via droplet spread<sup><a class="ref showRefEvent2" href="#">1</a></sup> but there are fears that aerosolized particles (generally &lt;5 micron diameter)<sup><a class="ref showRefEvent2" href="#">2</a></sup> could cause airborne transmission.<sup><a class="ref showRefEvent2" href="#">3</a></sup> Many organisations have advised the use of PPE for those undertaking certain activities that have been designated as aerosol generating procedures (AGPs) to minimise this risk. Examples include percutaneous tracheostomy and bronchoscopy<sup><a class="ref showRefEvent2" href="#">4</a></sup> but the quantitative evidence base for AGP designation is weak and the relative risk of each procedure unknown.<sup><a class="ref showRefEvent2" href="#">5</a></sup> To date aerosols generated during percutaneous tracheostomy have not been measured. Our previous study identified that background particle counts in most settings are too high to allow reliable aerosol detection. We had a unique opportunity to measure aerosol generation during percutaneous tracheostomy insertion in an ultra-clean operating theatre.
What problem does this paper attempt to address?